Public Sector Pension investment Board lowered its holdings in Innophos Holdings, Inc. (NASDAQ:IPHS) by 25.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 10,044 shares of the specialty chemicals company’s stock after selling 3,500 shares during the quarter. Public Sector Pension investment Board owned about 0.05% of Innophos Holdings worth $440,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Barings LLC acquired a new position in Innophos Holdings in the first quarter worth $200,000. Invictus RG acquired a new position in Innophos Holdings in the first quarter worth $244,000. Mason Street Advisors LLC boosted its stake in Innophos Holdings by 7.6% in the first quarter. Mason Street Advisors LLC now owns 4,550 shares of the specialty chemicals company’s stock worth $246,000 after purchasing an additional 321 shares in the last quarter. Pacad Investment Ltd. boosted its stake in Innophos Holdings by 19.5% in the second quarter. Pacad Investment Ltd. now owns 4,900 shares of the specialty chemicals company’s stock worth $215,000 after purchasing an additional 800 shares in the last quarter. Finally, Schroder Investment Management Group acquired a new position in Innophos Holdings in the first quarter worth $285,000. 94.26% of the stock is currently owned by institutional investors.
A number of research firms have commented on IPHS. BidaskClub lowered Innophos Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Zacks Investment Research raised Innophos Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th.
Innophos Holdings, Inc. (IPHS) opened at 49.42 on Wednesday. Innophos Holdings, Inc. has a 1-year low of $38.85 and a 1-year high of $58.22. The firm has a 50-day moving average price of $46.84 and a 200-day moving average price of $45.55. The firm has a market cap of $958.55 million, a price-to-earnings ratio of 21.58 and a beta of 0.89.
Innophos Holdings (NASDAQ:IPHS) last issued its quarterly earnings results on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.05. The company had revenue of $179.14 million for the quarter, compared to analyst estimates of $172.65 million. Innophos Holdings had a return on equity of 13.79% and a net margin of 6.46%. The company’s revenue for the quarter was down 1.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.63 EPS. On average, analysts expect that Innophos Holdings, Inc. will post $2.51 earnings per share for the current fiscal year.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.